Efficacy of Upadacitinib After NECS in Vitiligo

Sponsor
Jilin University
Study ID
NCT06454461
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The goal of this clinical trial is to investigate the efficacy of upadacitinib after NECS in participants with vitiligo. The main question it aims to answer is: whether the short time use of upadacitinib after NECS will improve NECS efficacy. Participants in the experimental group will receive upadacitinib after NECS, while Participants in the control group will receive NECS only.

Key Dates

Start date
Dec 4, 2024
Status verified
Aug 2024
Primary completion
Jun 1, 2026
Completion
Jun 1, 2029

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: A
    upadacitinib after autologous non-cultured epidermal cell suspension transplantation
  • No Intervention: B
    autologous non-cultured epidermal cell suspension transplantation

Primary Outcome Measure

T-VASI [ Time Frame: 6 months ]

Central Contacts

Related Studies